A lot of research has already been done with the hormone Leptin

Research coming from the world famous Harvard Medical School is being hailed by weight loss experts as a positive step in the complete eradication of obesity. Two existing drugs called Phenyl Butyric Acid and Tauroursodeoxycholic Acid which have already been licenced by the Food & Drug Administration in America have been extensively tested recently on lab mice and results are promising.

Previously these drugs have been approved to help men and women who suffer from cystic fibrosis and liver problems but in this new research project it was seen that these drugs have a positive effect on reducing the resistance to the build up of a hormone called Leptin which the body uses to regulate and suppress appetite.

A lot of research has already been done with the hormone Leptin but it has not been easy to replicate the actions of this hormone in the body. It is reckoned however that with the use of Phenyl Butyric Acid and Tauroursodeoxycholic Acid the process of the body producing Leptin may be facilitated more efficiently.

The research which is still at the early stage could end up with the use of these drugs to help overweight and obese individual regulate their appetites which would lead to weight loss. At present these drugs are not licenced for prescription for weight loss but since they have already undergone extensive testing for liver problems they could be fast tracked for approval by health authorities around the world.

The research which was led by Dr Umut Ozcan working at the Children’s Hospital Boston has been extensively reported on in the medical journal Cell Metabolism. At present the two most effective prescription weight loss medications which have proven track records in helping obese people lose weight safely are Reductil and Xenical.